CRISPR base editing applications for identifying cancer-driving mutations

Martin Pal, Marco J. Herold

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)
    2 Downloads (Pure)


    CRISPR base editing technology is a promising genome editing tool as (i) it does not require a DNA template to introduce mutations and (ii) it avoids creating DNA double-strand breaks, which can lead to unintended chromosomal alterations or elicit an unwanted DNA damage response. Given many cancers originate from point mutations in cancer-driving genes, the application of base editing for either modelling tumour development, therapeutic editing, or functional screening is of great promise. In this review, we summarise current DNA base editing technologies and will discuss recent advancements and existing hurdles for its usage in cancer research.
    Original languageEnglish
    Pages (from-to)269-280
    Number of pages12
    JournalBiochemical Society Transactions
    Issue number1
    Publication statusPublished - 01 Feb 2021


    Dive into the research topics of 'CRISPR base editing applications for identifying cancer-driving mutations'. Together they form a unique fingerprint.

    Cite this